Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

Thatcher, Nick, Prof ; Hirsch, Fred R, Prof ; Luft, Alexander V, MD ; Szczesna, Aleksandra, MD ; Ciuleanu, Tudor E, Prof ; Dediu, Mircea, MD ; Ramlau, Rodryg, Prof ; Galiulin, Rinat K, MD ; Bálint, Beatrix, MD ; Losonczy, György, Prof ; Kazarnowicz, Andrzej, MD ; Park, Keunchil, MD ; Schumann, Christian, Prof ; Reck, Martin, MD ; Depenbrock, Henrik, MD ; Nanda, Shivani, MS ; Kruljac-Letunic, Anamarija, PhD ; Kurek, Raffael, MD ; Paz-Ares, Luis, MD ; Socinski, Mark A, Prof

The lancet oncology, 2015-07, Vol.16 (7), p.763-774 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível